Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
Leila Khoja(AstraZeneca (United Kingdom)), Eshetu G. Atenafu(University Health Network), Stefan Suciu(European Organisation for Research and Treatment of Cancer), Serge Leyvraz(University of Lausanne), Takami Sato(Thomas Jefferson University), E. Marshall(Clatterbridge Cancer Centre NHS Foundation Trust), Ulrich Keilholz(Charité - Universitätsmedizin Berlin), Lisa Zimmer(German Cancer Research Center), Sapna P. Patel(The University of Texas MD Anderson Cancer Center), Sophie Piperno‐Neumann(Institut Curie), Josep M. Piulats(Institut Català d'Oncologia), Tero Kivelä(University of Helsinki), Claudia Pfoehler(MSH Medical School Hamburg – University of Applied Sciences and Medical University), Shailender Bhatia(University of Washington), Peter Huppert(Klinikum Darmstadt), L.B.J. van Iersel(Maastricht University Medical Centre), I. Jolanda M. de Vries(Radboud University Nijmegen), Nicolas Penel(Centre Oscar Lambret), Thomas J. Vogl(Goethe University Frankfurt), Tina Cheng(University of Calgary), Giammaria Fiorentini(Ospedali Riuniti Marche Nord), F. Mouriaux(Inserm), Ahmad A. Tarhini(UPMC Hillman Cancer Center), Poulam M. Patel(University of Nottingham), Richard D. Carvajal(Columbia University Irving Medical Center), Anthony M. Joshua(University Health Network)
Cited by 279Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis